347 related articles for article (PubMed ID: 16964386)
21. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
[TBL] [Abstract][Full Text] [Related]
22. Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer.
Wilkinson SJ; Kucukmetin A; Cross P; Darby S; Gnanapragasam VJ; Calvert AH; Robson CN; Edmondson RJ
Hum Pathol; 2008 Aug; 39(8):1197-204. PubMed ID: 18495208
[TBL] [Abstract][Full Text] [Related]
23. Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer.
Tchabo NE; Mhawech-Fauceglia P; Caballero OL; Villella J; Beck AF; Miliotto AJ; Liao J; Andrews C; Lele S; Old LJ; Odunsi K
Cancer Immun; 2009 Aug; 9():6. PubMed ID: 19705800
[TBL] [Abstract][Full Text] [Related]
24. Expression and functions of transmembrane mucin MUC13 in ovarian cancer.
Chauhan SC; Vannatta K; Ebeling MC; Vinayek N; Watanabe A; Pandey KK; Bell MC; Koch MD; Aburatani H; Lio Y; Jaggi M
Cancer Res; 2009 Feb; 69(3):765-74. PubMed ID: 19176398
[TBL] [Abstract][Full Text] [Related]
25. Expression of TAG-72 in ovarian cancer and its correlation with tumor stage and patient prognosis.
Ponnusamy MP; Venkatraman G; Singh AP; Chauhan SC; Johansson SL; Jain M; Smith L; Davis JS; Remmenga SW; Batra SK
Cancer Lett; 2007 Jun; 251(2):247-57. PubMed ID: 17210225
[TBL] [Abstract][Full Text] [Related]
26. Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma.
Macor P; Mezzanzanica D; Cossetti C; Alberti P; Figini M; Canevari S; Tedesco F
Cancer Res; 2006 Apr; 66(7):3876-83. PubMed ID: 16585216
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro.
Fu J; Luo B; Guo WW; Zhang QM; Shi L; Hu QP; Chen F; Xiao SW; Xie XX
Int J Clin Exp Pathol; 2015; 8(7):7786-97. PubMed ID: 26339343
[TBL] [Abstract][Full Text] [Related]
28. B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression.
Simon I; Katsaros D; Rigault de la Longrais I; Massobrio M; Scorilas A; Kim NW; Sarno MJ; Wolfert RL; Diamandis EP
Gynecol Oncol; 2007 Aug; 106(2):334-41. PubMed ID: 17498784
[TBL] [Abstract][Full Text] [Related]
29. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
[TBL] [Abstract][Full Text] [Related]
30. [The relation of peroxisome proliferator activated receptorbeta and Epithelial Ovarian Carcinoma].
Yang Y; Hou JQ; Ju HW; Yu ZH; Zhao ZW; Yang S; Yang HJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):630-2. PubMed ID: 17618585
[TBL] [Abstract][Full Text] [Related]
31. Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
Karam AK; Stempel M; Barakat RR; Morrow M; Gemignani ML
Gynecol Oncol; 2009 Mar; 112(3):490-5. PubMed ID: 19101713
[TBL] [Abstract][Full Text] [Related]
32. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
[TBL] [Abstract][Full Text] [Related]
33. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
34. The specific immune response to tumor antigen CP1 and its correlation with improved survival in colon cancer patients.
Liu FF; Dong XY; Pang XW; Xing Q; Wang HC; Zhang HG; Li Y; Yin YH; Fant M; Ye YJ; Shen DH; Zhang Y; Wang S; Chen WF
Gastroenterology; 2008 Apr; 134(4):998-1006. PubMed ID: 18395081
[TBL] [Abstract][Full Text] [Related]
35. The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer.
Brennan DJ; Ek S; Doyle E; Drew T; Foley M; Flannelly G; O'Connor DP; Gallagher WM; Kilpinen S; Kallioniemi OP; Jirstrom K; O'Herlihy C; Borrebaeck CA
Eur J Cancer; 2009 May; 45(8):1510-7. PubMed ID: 19272768
[TBL] [Abstract][Full Text] [Related]
36. Outcome of ovarian cancer patients who underwent incomplete surgical staging.
Panprom P; Lertkhachonsuk R
J Med Assoc Thai; 2008 Sep; 91(9):1323-30. PubMed ID: 18843859
[TBL] [Abstract][Full Text] [Related]
37. Human telomerase reverse transcriptase (hTERT) expression in borderline ovarian tumors: an immunohistochemical study.
Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
J Med Assoc Thai; 2009 Mar; 92(3):308-14. PubMed ID: 19301721
[TBL] [Abstract][Full Text] [Related]
38. [Alteration of early growth response 1 expression in gastroenterological cancers and its biological significance].
An J; Guo RF; Zhang L; Geng PL; Lü YY
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1384-9. PubMed ID: 18953875
[TBL] [Abstract][Full Text] [Related]
39. Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancer.
Joung JY; Yang SO; Jeong IG; Han KS; Seo HK; Chung J; Park WS; Lee KH
Int J Urol; 2007 Jul; 14(7):635-43. PubMed ID: 17645609
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a putative ovarian oncogene, elongation factor 1alpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells.
Sharma S; Tammela J; Wang X; Arnouk H; Driscoll D; Mhawech-Fauceglia P; Lele S; Kazim AL; Odunsi K
Clin Cancer Res; 2007 Oct; 13(19):5889-96. PubMed ID: 17908984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
